Mahesh Karande

Mahesh Karande

Chief Executive Officer chez OMEGA THERAPEUTICS, INC.

Fortune : - $ au 31/03/2024

51 ans
Health Technology
Consumer Services
Retail Trade

Profil

Mahesh Karande is currently the President, Chief Executive Officer & Director at Omega Therapeutics, Inc., as well as a Director at Ashvattha Therapeutics Inc and KSQ Therapeutics, Inc. Prior to his current roles, he was the President & Chief Executive Officer at Zikani Therapeutics, Inc. and held various leadership positions at Novartis, Inc., Novartis SA, and Novartis Pharma SAE.
He has a graduate degree from Georgia Institute of Technology, an undergraduate degree from the University of Mumbai, and an MBA from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/02/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Mahesh Karande

SociétésPosteDébut
OMEGA THERAPEUTICS, INC. Chief Executive Officer 01/06/2019
Director/Board Member 08/12/2022
Director/Board Member 31/05/2023
Tous les postes actifs de Mahesh Karande

Anciens postes connus de Mahesh Karande

SociétésPosteFin
Chief Executive Officer 01/03/2019
Novartis Pharma SAE President 01/04/2017
President 01/04/2017
Corporate Officer/Principal 01/04/2017
Voir l'expérience en détail de Mahesh Karande

Formation de Mahesh Karande

Georgia Institute of Technology Graduate Degree
University of Mumbai Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mahesh Karande

Relations

45

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
OMEGA THERAPEUTICS, INC.

Health Technology

Entreprise privées6

Health Technology

Retail Trade

Health Technology

Novartis Pharma SAE

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mahesh Karande